“…The discussion on using novel disease-specific venom-based protein/peptide/toxin along with currently available FDA approved drugs as combinatorial treatment, such as a family of novel types of antimicrobial agents, were also encouraged to be discussed in these contexts. For examples, an overview of some selected promising snake and ant venom-based peptides/toxins potentially able to address the forthcoming challenges in this field were included [9,10]. In addition, four detailed review articles openly discuss the venom proteins/peptides in different species of snake venoms and toad toxins [11,12,13]; moreover, plant toxins from Bouganin naturally targeted, as immunotoxins [14], mammalian receptors and demonstrated high specificity and selectivity towards defined ion channels of cell membranes and receptors.…”